First International Bank & Trust Bristol Myers Squibb CO Transaction History

First International Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $61,884 - $69,196	-1,069 Reduced 17.38%	5,082 $294,000
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $7,517 - $8,347	118 Added 1.96%	6,151 $393,000
Q1 2023 Apr 14, 2023	BUY	$65.71 - $74.53 $32,263 - $36,594	491 Added 8.86%	6,033 $418,000
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $3,903 - $4,622	57 Added 1.04%	5,542 $399,000
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $713 - $421,467	5,485 New	5,485 $390,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First International Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First International Bank & Trust with notifications on news.